ENErik Noppa

Erik Noppa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Erik Noppa has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Answer to Gricourt et al.

    by Erik Noppa, Karuna Dahlberg, Kristofer F. Nilsson

  • Open Access

    General Anaesthesia Versus Spinal Anaesthesia for Outpatient Total Hip and Knee Arthroplasty: A Randomised Trial Protocol

    by Erik Noppa, Karuna Dahlberg, Alex de Leon, Maziar Mohaddes, Anna Philipson, Peter Wildeman, Kristofer F. Nilsson

    Introduction: Same‐day discharge after primary total hip arthroplasty (THA) and total knee arthroplasty (TKA) is increasing, but the optimal anaesthetic technique for outpatient pathways remains uncertain. Neuraxial anaesthesia is widely recommended based on observational evidence, whereas fast‐track programmes using short‐acting total intravenous anaesthesia may facilitate early mobilisation and discharge. No randomised controlled trial has compared general anaesthesia (GA) with spinal anaesthesia (SA) specifically in outpatient primary THA/TKA using a same‐day discharge target. Methods and Analysis: GASPS is a pragmatic, multicentre, parallel‐group superiority randomised controlled trial. Adults scheduled for outpatient primary THA or TKA will be randomised 1:1 to GA or SA, with stratification by site and procedure (THA/TKA). The primary outcome is successful same‐day discharge (discharge on the day of surgery) without readmission within 48 h after discharge. The five key secondary outcomes are time to fulfilment of hospital discharge indicators, quality‐of‐recovery (QoR‐15) trajectories over postoperative Days 1–35, patients' qualitative experiences of anaesthesia and recovery, cost per quality‐adjusted life‐year and safety (adverse events); all remaining outcomes—including pain, postoperative nausea and vomiting, opioid consumption, mobilisation and patient‐reported outcomes (EQ‐5D‐5L and HOOS/KOOS)—are exploratory. An embedded qualitative study will explore patient experiences using semi‐structured interviews, and an economic evaluation will compare costs and outcomes from healthcare and societal perspectives. Analyses will follow the intention‐to‐treat principle; a group sequential design with O'Brien‐Fleming boundaries is planned for an interim analysis. Approval has been obtained from the Swedish Medical Products Agency. Written informed consent will be obtained from all participants. Results will be disseminated through peer‐reviewed publications, conference presentations and reporting in the EU Clinical Trials Information System (CTIS). Conclusion: This study is designed to determine the most effective anaesthetic method for same‐day discharge after primary TKA and THA. With increasing outpatient surgeries, this study will be helpful for optimisation of outpatient processes. Trial Registration: EU CT/CTIS: 2024‐520127‐89‐00. ClinicalTrials.gov : NCT07334132


  • Open Access

    Return to work after volar or combined plating of type C distal radius fracture: a secondary analysis of a randomised clinical trial

    by Erik Noppa, Marcus Sagerfors, Eva Lundqvist

    Background: Distal radius fracture (DRF) is the most common of fractures, accounting for 18% of all fractures. The ability to return to work is an important outcome for both society and the individual, but there is a large variation among patients in how much time off work is required. The choice of treatment is likely an important factor. Methods: This study was a secondary analysis of an earlier published randomised clinical trial comparing volar locking plate fixation with combined dorsal and volar plate fixation of AO type C DRF. In the present study, we examined the the duration of sick leave among patients who were in the workforce at the time of fracture. Results: There were 84 cases included in this analysis.Combined plating was associated with a significantly longer time to return to work following a type C DRF, in comparison to treatment with a volar locking plate. The crude difference was 0.67 months ( p = 0.33; 95% CI: 0.85–1,26 months), and 0.65 months ( p = 0.15; 95% CI: 0.13–1.17) when adjusting for differences in manual labour indicating a statistically significant difference time until return to work. Conclusions: Sick leave is an important contributor to total costs in patients with DRF, and more invasive treatments like combined plating are associated with longer sick leave. Our results indicate a longer time until return to work in the combined plating group, possibly due to more extensive soft tissue dissection. We recommend a restrictive use of combined plating. Trial registration: The study was registered in the Swedish research database FoU in Sweden (registration number: 274674) on the 4th of August 2020.


  • Open Access

    A retrospective cohort of smartpilot view–assisted effect-site TCI anaesthesia in primary total hip and knee arthroplasty

    by Erik Noppa, Alexander Persson, Henrik Öhrström, Per Wretenberg, Eva Lundqvist

    Background: Primary total hip arthroplasty and total knee arthroplasty are common surgical procedures that require effective perioperative care to ensure early mobilisation, reduced complications, and shortened hospital stay. Effect-site target-controlled infusion (TCI) combined with SmartPilot View (SPV) is a novel approach to total intravenous anaesthesia that may improve anaesthetic precision and reduce postoperative side effects. However, it has not been thoroughly evaluated in joint arthroplasty. The aim of this study was to evaluate the early anaesthetic outcomes in hip and knee arthroplasty patients following the implementation of effect-site TCI and SPV. Methods: We conducted a retrospective cohort study including 2316 procedures (2210 patients) at Örebro University Hospital, Lindesberg, Sweden, between 2018 and 2023. Two groups were compared: pre-implementation (2018–2019, n = 1258) using plasma-targeted TCI without SPV, and post-implementation (2022–2023, n = 1058) using effect-site TCI with SPV. Patients from 2020 to 2021 were excluded due to the COVID-19 pandemic and the overlap of methods during implementation. Data were extracted from the Swedish Perioperative Register. The primary outcome was the incidence of postoperative nausea and vomiting (PONV). Secondary outcomes included length of stay in the post-anaesthesia care unit (phase II), postoperative pain, and surgical duration. Results: PONV incidence decreased significantly from 8.4% to 3.0% after implementation ( p < 0.001; adjusted OR: 0.36, 95% CI: 0.23–0.55). Median post-anaesthesia care unit stay decreased by 70 min (95% CI: 61–78 min; p < 0.001). Postoperative pain scores were slightly lower in the post-implementation group (median numeric rating scale 7 vs. 5; p < 0.001). Surgical duration increased marginally (84 vs. 87 min; p = 0.003). Conclusions: Implementation of effect-site TCI and SPV in hip and knee arthroplasty was associated with significantly reduced PONV and shorter post-anaesthesia care unit stay, suggesting improved early postoperative recovery. Clinical trial number: Not applicable.